Voluntary Medical Male Circumcision: What Gets Counted

This table from Px Wire January-March 2014 Volume 7, No.1 examines why the global systems for tracking voluntary medical male circumcision are lagging behind the actual progress being made.

AIDS Vaccine Science for Busy Advocates – Current AIDS Vaccine R&D Pipeline

One-pager reviewing what we’ve learned from previous efficacy trials, the product pipeline and where we are today and future directions toward finding a vaccine that works.

AIDS Vaccine Science for Busy Advocates – RV144: Building on a breakthrough

A one-page document describing RV144, the first AIDS vaccine trial to show protection against HIV in humans, and plans to further this research.

AIDS Vaccine Science for Busy Advocates – Passive Immunization: An important piece of the puzzle

A one-page document describing passive immunization, the transfer of pre-made antibodies, and its potential for HIV prevention.

HIV Vaccines: Key messages

This is a three-page document providing main points surrounding vaccine research. For a shorter one-page version of this, click here.

Pre-Exposure Prophylaxis: An introductory factsheet

This introductory 2-page document defines PrEP, reviews the scientific evidence to date, and outlines key research, regulatory and advocacy issues going forward. This factsheet is part of a series on emerging HIV prevention strategies.

Treatment as Prevention: An introductory factsheet

This introductory 2-page document defines treatment as prevention, reviews the scientific evidence behind it, and outlines implementation advocacy priorities. The factsheet is part of a series on emerging HIV prevention strategies.

Microbicides for HIV Prevention: An introductory factsheet

This introductory 2-page document defines microbicides and reviews the state of research on some leading candidates.

Multipurpose Prevention Technologies (MPTs): An introductory factsheet

This introductory 2-page document makes the case for why women need prevention options that protect them against multiple risks—HIV, STIs and/or pregnancy—and discusses the products that are being studied for this purpose. The factsheet is part of a series on emerging HIV prevention strategies.

PrEP Primer (Chinese)

This document, developed by 2012 AVAC Advocacy Fellow Cai Lingping, provides background information on pre-exposure prophylaxis, reviews the evidence base and planned trials, and discusses key issues for Chinese advocates. It explores implementation challenges and the funding landscape for continued research.